Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments

J Clin Psychiatry. 1998 Jun;59(6):279-88. doi: 10.4088/jcp.v59n0602.

Abstract

Background: Many patients with unipolar depression experience a return of depressive symptoms while taking a constant maintenance dose of an antidepressant.

Method: All cited studies were found using computerized literature searches of the MEDLINE database since 1966.

Results: The return of depressive symptoms during maintenance antidepressant treatment has occurred in 9% to 57% of patients in published trials. Possible explanations include loss of placebo effect, pharmacologic tolerance, increase in disease severity, change in disease pathogenesis, the accumulation of a detrimental metabolite, unrecognized rapid cycling, and prophylactic inefficacy.

Conclusion: Although several strategies have been proposed to overcome the loss of antidepressant efficacy, double-blind controlled studies are needed to ascertain the optimal strategy for this perplexing clinical problem.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Adult
  • Aged
  • Antidepressive Agents / pharmacokinetics
  • Antidepressive Agents / therapeutic use*
  • Antidepressive Agents, Tricyclic / pharmacokinetics
  • Antidepressive Agents, Tricyclic / therapeutic use
  • Clinical Trials as Topic
  • Depressive Disorder / drug therapy
  • Depressive Disorder / prevention & control*
  • Depressive Disorder / psychology
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Drug Tolerance
  • Female
  • Humans
  • MEDLINE
  • Male
  • Middle Aged
  • Monoamine Oxidase Inhibitors / pharmacokinetics
  • Monoamine Oxidase Inhibitors / therapeutic use
  • Placebo Effect
  • Research Design
  • Secondary Prevention
  • Selective Serotonin Reuptake Inhibitors / pharmacokinetics
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Severity of Illness Index
  • United States

Substances

  • Antidepressive Agents
  • Antidepressive Agents, Tricyclic
  • Monoamine Oxidase Inhibitors
  • Serotonin Uptake Inhibitors